Sessa C - Search Results

1

The combination of yondelis and cisplatin is synergistic against human tumor xenografts.

D'Incalci M, Colombo T, Ubezio P, Nicoletti I, Giavazzi R, Erba E, Ferrarese L, Meco D, Riccardi R, Sessa C, Cavallini E, Jimeno J, Faircloth GT. D'Incalci M, et al. Among authors: sessa c. Eur J Cancer. 2003 Sep;39(13):1920-6. doi: 10.1016/s0959-8049(03)00490-8. Eur J Cancer. 2003. PMID: 12932672

2

Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.

Erba E, Sen S, Sessa C, Vikhanskaya FL, D'Incalci M. Erba E, et al. Among authors: sessa c. Br J Cancer. 1994 Feb;69(2):205-11. doi: 10.1038/bjc.1994.40. Br J Cancer. 1994. PMID: 8297715 Free PMC article.

3

Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.

Sessa C, Perotti A, Noberasco C, De Braud F, Gallerani E, Cresta S, Zucchetti M, Viganò L, Locatelli A, Jimeno J, Feilchenfeldt JW, D'Incalci M, Capri G, Ielmini N, Gianni L. Sessa C, et al. Eur J Cancer. 2009 May;45(7):1153-1161. doi: 10.1016/j.ejca.2008.11.019. Epub 2008 Dec 27. Eur J Cancer. 2009. PMID: 19114300 Clinical Trial.

4

Activity of aphidicolin glycinate alone or in combination with cisplatin in a murine ovarian tumor resistant to cisplatin.

Damia G, Tagliabue G, Zucchetti M, Davoli E, Sessa C, Cavalli F, D'Incalci M. Damia G, et al. Among authors: sessa c. Cancer Chemother Pharmacol. 1992;30(6):459-64. doi: 10.1007/BF00685597. Cancer Chemother Pharmacol. 1992. PMID: 1394802

5

Lack of effect of cisplatin on i.v. L-PAM plasma pharmacokinetics in ovarian cancer patients.

Zucchetti M, D'Incalci M, Willems Y, Cavalli F, Sessa C. Zucchetti M, et al. Among authors: sessa c. Cancer Chemother Pharmacol. 1988;22(1):87-9. doi: 10.1007/BF00254189. Cancer Chemother Pharmacol. 1988. PMID: 3396150

6

DNA minor groove binding ligands: a new class of anticancer agents.

D'Incalci M, Sessa C. D'Incalci M, et al. Among authors: sessa c. Expert Opin Investig Drugs. 1997 Jul;6(7):875-84. doi: 10.1517/13543784.6.7.875. Expert Opin Investig Drugs. 1997. PMID: 15989650

7

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours.

Sessa C, Cresta S, Noberasco C, Capri G, Gallerani E, De Braud F, Zucchetti M, D'Incalci M, Locatelli A, Marsoni S, Corradino I, Minoia C, Zintl P, Gianni L. Sessa C, et al. Eur J Cancer. 2009 Aug;45(12):2116-22. doi: 10.1016/j.ejca.2009.04.002. Epub 2009 May 4. Eur J Cancer. 2009. PMID: 19419856 Clinical Trial.

8

Trabectedin in ovarian cancer: could we expect more?

Sessa C, D'Incalci M. Sessa C, et al. Ann Oncol. 2011 Jan;22(1):7-8. doi: 10.1093/annonc/mdq641. Epub 2010 Nov 8. Ann Oncol. 2011. PMID: 21059638 Free article. No abstract available.

9

In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743).

Ghielmini M, Colli E, Erba E, Bergamaschi D, Pampallona S, Jimeno J, Faircloth G, Sessa C. Ghielmini M, et al. Among authors: sessa c. Ann Oncol. 1998 Sep;9(9):989-93. doi: 10.1023/A:1008430827281. Ann Oncol. 1998. PMID: 9818073 Free article.

10

Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin.

Colombo T, Parisi I, Zucchetti M, Sessa C, Goldhirsch A, D'Incalci M. Colombo T, et al. Among authors: sessa c. Ann Oncol. 1999 Apr;10(4):391-5. doi: 10.1023/a:1008309916974. Ann Oncol. 1999. PMID: 10370780 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters